Stuart J Gallagher

5PUBLICATIONS
11CO-AUTHORS
Molecular targetsPredictive and prognostic markersMechanobiologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 10, 2024
BET inhibition sensitizes innate checkpoint inhibitor resistant melanoma to anti-CTLA-4 treatment.

Hsin-Yi Tseng, Sara Alavi, Stuart Gallagher

|Apr 07, 2020
Co-targeting bromodomain and extra-terminal proteins and MCL1 induces synergistic cell death in melanoma.

Hsin-Yi Tseng, Jan Dreyer, Abdullah Al Emran

|May 18, 2018
Simulation of melanoblast displacements reveals new features of developmental migration.

Pascal Laurent-Gengoux, Valérie Petit, Zackie Aktary

|Dec 07, 2017
HDAC inhibitors restore BRAF-inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma.

Stuart J Gallagher, Dilini Gunatilake, Kimberley A Beaumont

Pageof 1